July 10, 2023 - Alerts and Newsletters

        CMS Proposes to Make Lump-Sum Payments to Hospitals for Underpayments for Drugs Purchased Through the 340B Program During 2018-2022

        Last week CMS issued its anticipated proposed rule to implement the Supreme Court’s decision last year which ruled that CMS’ reduction in Medicare payments for Part B outpatient drugs purchased through the 340B program violated the Medicare statute. CMS proposes to make lump-sum payments to 340B hospitals while reducing future payments for non-drug items and services by 0.5% starting in 2025 and which it anticipates will continue for 16 years.

        Background

        Before CY 2018, Medicare paid average sales price (“ASP”) plus 6% for Part B covered outpatient drugs. For CY 2018, CMS reduced the payment rate for drugs purchased under the 340B program to ASP minus 22.5%. To maintain the statutory budget neutrality requirement, CMS made a corresponding increase to all hospitals (both 340B and non-340B hospitals) for non-drug items and services starting in CY 2018.

        In June of 2022 the U.S. Supreme Court agreed with the hospitals and ruled that CMS’ payment reduction violated the Medicare statute. CMS reinstituted the prior payment rate of ASP + 6% for 340B drugs paid on or after September 28, 2022, but left open the question of how CMS would reimburse 340B hospitals for the income they did not receive for CYs 2018 through most of 2022. CMS also left open how it would recapture the higher payments made to all hospitals for non-drug items and services (including those 340B hospitals).

        Proposed remedy

        To correct the underpayments to 340B hospitals during CY 2018 through approximately September 27, 2022, CMS proposes to make a lump-sum payment to those 340B hospitals. CMS estimates this payment amount to be worth approximately $10.5 billion. CMS estimates that it paid or reprocessed many CY 2022 claims at the higher, correct payment amount, which it estimates to be worth $1.5 billion, meaning that the lump sum amount owed to hospitals is approximately $9 billion. CMS anticipates that its MACs will make these one-time payments at the end of CY 2023 or early in CY 2024.

        CMS has provided a link to a spreadsheet that shows how much it estimates each hospital will receive as a lump-sum payment:

        https://www.cms.gov/medicare/medicare-fee-for-service-payment/hospitaloutpatientpps

        Beneficiary copayments

        Medicare proposes to include the beneficiaries’ copay amounts in the lump sum payment. Hospitals therefore are not to bill the patients for these amounts.

        Prospective offset for higher payments for non-drug items and services from CY 2018-2022

        As noted above, to maintain budget neutrality, CMS says that it must recapture the higher payments made to all hospitals (both 340B and non-340B) during CYs 2018-2022. CMS estimates that it must recapture $7.8 billion from all hospitals. To achieve this recapture without financially harming the hospitals at once, CMS proposes to reduce outpatient prospective payment system (OPPS) payments by 0.5% starting in CY 2025 until it recaptures the overpayment amount. CMS estimates that this recapture process will take 16 years.

        Public comments

        CMS seeks comments on its proposal by September 5, 2023. Please do not hesitate to contact us if you have any thoughts about how CMS can better achieve its mandate, or if you have any questions.

        Associated People

        Firm Highlights

        Blog

        Run Don’t Walk: The Implication of “While Supplies Last” Prize Promotions

        This month a big-chain grocery store has been offering daily mystery boxes during specific timed drops on a first-come, first-served basis, to users...
        Blog

        Maine’s Noncompete Statute is Reshaped for Health Care Workers: What You Need to Know

        Employers of individuals who are licensed under state law to perform, or provide, health care services in the State of Maine should be prepared for...
        Media Mentions

        Steven Davis Featured in the Environmental Business Journal

        Steven Davis, President of Verrill Strategic Consulting, was recently interviewed and featured in the Environmental Business Journal, Volume 39...
        Blog

        What is a Bonus for Purposes of ERISA?

        An ongoing dispute about a Department of Labor advisory opinion published last September raises a basic but unanswered question under the ERISA: What...
        Media Mentions

        Verrill Recognized by WMTW for Partnership Supporting Hunger Relief in Maine

        Verrill was recently featured in coverage by WMTW News 8 for its role in a collaborative effort to combat food insecurity across southern...
        Press Releases

        33 Verrill Attorneys, Across Four Offices, Recognized in the 2026 Chambers USA Guide

        BOSTON, Massachusetts, PORTLAND, Maine, WESTPORT, Connecticut, and WASHINGTON, D.C. – Verrill has been recognized as a Leading Firm in 14...
        Blog

        Will the Knicks Beat the Spurs? (Are Prediction Market Event Contracts Gambling?)

        For those of you who like to keep score, currently 18 states are engaged in litigation over prediction markets, such as Kalshi and Polymarket,...
        Alerts and Newsletters

        DOJ Announces Faster Review and Enhanced Enforcement for Benefits-Fraud FCA Matters

        On May 27, 2026, the U.S. Department of Justice (DOJ) Civil Division issued a new memorandum, “Accelerating Review and Enhancing Enforcement in...
        Alerts and Newsletters

        DOJ Announces Minnesota Health Care Fraud Takedown; Signals Intensified Medicaid Enforcement Nationwide

        On May 21, the Department of Justice (“DOJ”) announced a first-of-its kind Minnesota Health Care Fraud Takedown charging 15 defendants, including...
        Media Mentions

        Lauren Galvin Quoted in Massachusetts Lawyers Weekly on Arbitration and Anti-SLAPP Protections

        Verrill Partner Lauren Galvin was recently featured in a Massachusetts Lawyers Weekly article highlighting a notable Superior Court decision...
        Blog

        Section 530A Accounts: What Employers Should Consider Before Offering Contributions to “Trump” Accounts

        Section 530A accounts, commonly referred to as Trump accounts, have attracted attention since the enactment of the One Big Beautiful Bill Act in...
        Blog

        Navigating PBM Reform: Regulatory Changes, Market Shifts, and Practical Guidance for ERISA Fiduciaries

        Pharmacy Benefit Manager (“PBM”) arrangements have long relied on rebates with limited transparency into true drug costs. Recent regulatory and...